Polycyclic aromatic hydrocarbons and childhood asthma

European Journal of Epidemiology

Volumn 30, Issue 2, 2015, Pages 91-101

  Karimi, Parisa ^a,c   Peters, Kamau O ^a   Bidad, Katayoon ^b   Strickland, Paul T ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Childhood asthma; Incidence; Morbidity; Mortality; Polycyclic aromatic hydrocarbons; Prevalence

Indexed keywords

POLYCYCLIC AROMATIC HYDROCARBON; AIR POLLUTANT; ALLERGEN; PASSIVE SMOKING;

AIR POLLUTION; ASTHMA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; EXPOSURE; FORCED EXPIRATORY VOLUME; HUMAN; INCIDENCE; INDOOR AIR POLLUTION; MORBIDITY; MORTALITY; OCCUPATIONAL EXPOSURE; PREVALENCE; REVIEW; RISK FACTOR; SMOKING; SOCIAL STATUS; URBAN AREA; ADVERSE EFFECTS; AIR POLLUTANT; CHILD; PASSIVE SMOKING; TOXICITY;

AIR POLLUTANTS; AIR POLLUTION, INDOOR; ALLERGENS; ASTHMA; CHILD; HUMANS; POLYCYCLIC HYDROCARBONS, AROMATIC; PREVALENCE; TOBACCO SMOKE POLLUTION;

EID: 84925161915     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-9988-6     Document Type: Review

References (151)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720–45.
2. Lai C, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2009;64:476–83.
3. Akinbami LJ. The Stat of childhood asthma, United States, 1980–2005. Advance data from vita and health statistics; no 381. Hyattsville, MD: National Center for Health Statistics; 2006.
4. Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, Scalia MS, Akinbami LJ. National surveillance for asthma—United States, 1980–2004. Department of Health and Human Services, Centers for Disease Control and Prevention; 2007.
5. National Heart, Lung, and Blood Institute. Morbidity and mortality: chart book on cardiovascular, lung, and blood diseases. Bethesda, Md: National Institutes of Health; 2009.
6. Braman SS. The global burden of asthma. Chest. 2006;130(1 Suppl):4S–12S.
7. Almqvist C, Worm M, Leynaert B. Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy. 2008;63:47–57.
8. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40–70.
9. Smyth RL. Asthma: a major pediatric health issue. Respir Res. 2002;3(Suppl 1):S3–7.
10. Measuring childhood asthma prevalence before and after the 1997 redesign of the National Health Interview Survey—United States. MMWR Morb Mortal Wkly Rep. 2000;49:908–11.
11. Bryant-Stephens T. Asthma disparities in urban environments. J Allergy Clin Immunol. 2009;123:1199–206.
12. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics. 2002;110:315–22.
13. Britton J. Asthma’s changing prevalence. BMJ. 1992;304:857–8.
14. Woolcock AJ. Asthma-disease of a modern lifestyle. Med J Aust. 1996;165:358–9.
15. Cookson J. Prevalence rates of asthma in developing countries and their comparison with those in Europe and North America. Chest. 1987;91:97S–103S.
16. Gupta RS, Carrión-Carire V, Weiss KB. The widening black/white gap in asthma hospitalizations and mortality. J Allergy Clin Immunol. 2006;117:351–8.
17. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980–2007. Pediatrics. 2009;123:S131–45.
18. Cairns CB. Acute asthma exacerbations: phenotypes and management. Clin Chest Med. 2006;27:99–108.
19. Calamelli E, Ricci G, Pession A. Recent advances in diagnosis and therapy of allergic rhinitis and asthma in childhood. Eur Ann Allergy Clin Immunol. 2012;44:215–24.
20. Nishimuta T, Kondo N, Hamasaki Y, Morikawa A, Nishima S. Childhood asthma. Allergol Int. 2011;60:147–69.
21. McFadden E, Warren EL. Observations on asthma mortality. Ann Intern Med. 1997;127(2):142–7.
22. Anderson HR, Gupta R, Kapetanakis V, Asher MI, Clayton T, Robertson CF, Strachan DP. ISAAC streeting committee. International correlations between indicators of prevalence, hospital admissions and mortality for asthma in children. Int J Epidemiol. 2008;37(3):573–82.
23. Herzog R, Cunningham-Rundles S. Pediatric asthma: natural history, assessment, and treatment. Mt Sinai J Med. 2011;78:645–60.
24. Miller JE. The effects of race/ethnicity and income on early childhood asthma prevalence and health care use. Am J Public Health. 2000;90:428–30.
25. Salam MT, Li YF, Langholz B, Gilliland FD. Early-life environmental risk factors for asthma: findings from the Children’s Health Study. Environ Health Perspect. 2004;112:760–5.
26. Sears MR, Holdaway MD, Flannery EM, Herbison GP, Silva PA. Parental and neonatal risk factors for atopy, airway hyper-responsiveness, and asthma. Arch Dis Child. 1996;75:392–8.
27. Aligne CA, Auinger P, Byrd RS, Weitzman M. Risk factors for pediatric asthma. Contributions of poverty, race, and urban residence. Am J Respir Crit Care Med. 2000;162:873–7.
28. MacDowell AL, Bacharier LB. Infectious triggers of asthma. Immunol Allergy Clin North Am. 2005;25:45–66.
29. Shaheen SO. Obesity and asthma: cause for concern? Clin Exp Allergy. 1999;29:291–3.
30. Infante-Rivard C, Amre D, Gautrin D, Malo JL. Family size, day-care attendance, and breastfeeding in relation to the incidence of childhood asthma. Am J Epidemiol. 2001;153:653–8.
31. Devereux G, Seaton A. Diet as a risk factor for atopy and asthma. J Allergy Clin Immunol. 2005;115:1109–17.
32. Guilbert TW, Morgan WJ, Zeiger RS, Bacharier LB, Boehmer SJ, Krawiec M, Larsen G, Lemanske RF, Liu A, Mauger DT, Sorkness C, Szefler SJ, Strunk RC, Taussig LM, Martinez FD. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol. 2004;114:1282–7.
33. Bacharier LB, Guilbert TW. Diagnosis and management of early asthma in preschool-aged children. J Allergy Clin Immunol. 2012;130:287–96.
34. Oddy WH, Holt PG, Sly PD, Read AW, Landau LI, Stanley FJ, Kendall GE, Burton PR. Association between breast feeding and asthma in 6 year old children: findings of a prospective birth cohort study. BMJ. 1999;319:815–9.
35. Peat JK, Allen J, Oddy W, Webb K. Breastfeeding and asthma: appraising the controversy. Pediatr Pulmonol. 2003;35:331–4.
36. Karimi P, Shahrokni A, Moradi S. Evidence for US Preventive Services Task Force (USPSTF) Recommendations against routine mammography for females between 40–49 years of age. Asian Pac J Cancer Prev. 2013;14:2137–9.
37. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ. 2002;324:763.
38. Gern JE. Viral and bacterial infections in the development and progression of asthma. J Allergy Clin Immunol. 2000;105:S497–502.
39. Massie J. Exercise-induced asthma in children. Pediatric Drugs. 2002;4:267–78.
40. Mireku N, Wang Y, Ager J, Reddy RC, Baptist AP. Changes in weather and the effects on pediatric asthma exacerbations. Ann Allergy Asthma Immunol. 2009;103:220–4.
41. Wu F, Takaro TK. Childhood asthma and environmental interventions. Environ Health Perspect. 2007;115:971–5.
42. Rumchev K, Spickett J, Bulsara M, Phillips M, Stick S. Association of domestic exposure to volatile organic compounds with asthma in young children. Thorax. 2004;59:746–51.
43. Burton A. Children’s health: methylation links prenatal PAH exposure to asthma. Environ Health Perspect. 2009;117:A195.
44. Delfino RJ. Epidemiologic evidence for asthma and exposure to air toxics: linkages between occupational, indoor, and community air pollution research. Environ Health Perspect. 2002;110:573.
45. Cerniglia CE. Biodegradation of polycyclic aromatic hydrocarbons. Curr Opin Biotechnol. 1993;4:331–8.
46. Connell DW, Hawker DW, Warne MJ, Vowles PP. Polycyclic aromatic hydrocarbons (PAHs). In: Connell DW, editor. Basic concepts of environmental chemistry. Boca Raton, FL: CRC Press; 1997. p. 205–17.
47. Srogi K. Monitoring of environmental exposure to polycyclic aromatic hydrocarbons: a review. Environ Chem Lett. 2007;5:169–95.
48. Franco SS, Nardocci AC, Günther WMR. PAH biomarkers for human health risk assessment: a review of the state-of-the-art. Cad Saude Publica. 2008;24:S569–80.
49. Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet. 2006;21:257–76.
50. Baird WM, Hooven LA, Mahadevan B. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen. 2005;45:106–14.
51. Jongeneelen FJ. Benchmark guideline for urinary 1-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons. Ann Occup Hyg. 2001;45:3–13.
52. Chuang JC, Callahan PJ, Lyu CW, Wilson NK. Polycyclic aromatic hydrocarbon exposures of children in low-income families. J Expo Anal Environ Epidemiol. 1999;9:85–98.
53. Strickland P, Kang D. Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. Toxicol Lett. 1999;108:191–9.
54. Rappaport SM, Waidyanatha S, Serdar B. Naphthalene and its biomarkers as measures of occupational exposure to polycyclic aromatic hydrocarbons. J Environ Monit. 2004;6:413–6.
55. Ramesh A, Walker SA, Hood DB, Guillén MD, Schneider K, Weyand EH. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol. 2004;23:301–33.
56. Kamangar F, Karimi P. The state of nutritional epidemiology: why we are still unsure of what we should eat? Arch Iran Med. 2013;16:483–6.
57. Lioy PL, Waldman JM, Greenberg A, Harkov R, Pietarinen C. The Total Human Environmental Exposure Study (THEES) to benzo (a) pyrene: comparison of the inhalation and food pathways. Arch Environ Health. 1998;43:304–12.
58. Falco G, Domingo JL, Llobet JM, Teixido A, Casas C, Muller L. Polycyclic aromatic hydrocarbons in foods: human exposure through the diet in Catalonia, Spain. J Food Prot. 2003;66:2325–31.
59. Wenzl T, Simon R, Anklam E, Kleiner J. Analytical methods for polycyclic aromatic hydrocarbons (PAHs) in food and the environment needed for new food legislation in the European Union. Trends Analyt Chem. 2006;25:716–25.
60. Kobayashi R, Okamoto RA, Maddalena RL, Kado NY. Polycyclic aromatic hydrocarbons in edible grain: a pilot study of agricultural crops as a human exposure pathway for environmental contaminants using wheat as a model crop. Environ Res. 2008;107:145–51.
61. Gadde B, Bonnet S, Menke C, Garivait S. Air pollutant emissions from rice straw open field burning in India, Thailand and the Philippines. Environ Pollut. 2009;157:1554–8.
62. Nam JJ, Thomas GO, Jaward FM, Steinnes E, Gustafsson O, Jones KC. PAHs in background soils from Western Europe: influence of atmospheric deposition and soil organic matter. Chemosphere. 2008;70:1596–602.
63. Pufulete M, Battershill J, Boobis A, Fielder R. Approaches to carcinogenic risk assessment for polycyclic aromatic hydrocarbons: a UK perspective. Regul Toxicol Pharmacol. 2004;40:54–66.
64. Fagundes RB, Abnet CC, Strickland PT, Kamangar F, Roth MJ, Taylor PR, Dawsey SM. Higher urine 1-hydroxy pyrene glucuronide (1-OHPG) is associated with tobacco smoke exposure and drinking mate in healthy subjects from Rio Grande do Sul, Brazil. BMC Cancer. 2006;6:139.
65. Kang D, Rothman N, Cho SH, Lim HS, Kwon HJ, Kim SM, Schwartz B, Strickland PT. Association of exposure to polycyclic aromatic hydrocarbons (estimated from job category) with concentration of 1-hydroxypyrene glucuronide in urine from workers at a steel plant. Occup Environ Med. 1995;52:593–9.
66. Van Rooij JG, Veeger MM, Bodelier-Bade MM, Scheepers PT, Jongeneelen FJ. Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1-hydroxypyrene in urine. Int Arch Occup Environ Health. 1994;66:55–65.
67. Lee KH, Vermeulen R, Lenters V, Cho SH, Strickland PT, Kang D. Determinants of urinary 1-hydroxypyrene glucuronide in South Korean children. Int Arch Occup Environ Health. 2009;82:961–8.
68. Taioli E, Sram RJ, Garte S, Kalina I, Popov TA, Farmer PB. Effects of polycyclic aromatic hydrocarbons (PAHs) in environmental pollution on exogenous and oxidative DNA damage (EXPAH project): description of the population under study. Muta Res. 2007;620:1–6.
69. Horwood L, Fergusson D, Shannon F. Social and familial factors in the development of early childhood asthma. Pediatrics. 1985;75:859–68.
70. Hogstedt C, Jansson C, Hugosson M, Tinnerberg H, Gustavsson P. Cancer incidence in a cohort of Swedish chimney sweeps, 1958–2006. Am J Public Health. 2013;103:1708–14.
71. Liu HH, Lin MH, Chan CI, Chen HL. Oxidative damage in foundry workers occupationally co-exposed to PAHs and metals. Int J Hyg Environ Health. 2010;213:93–8.
72. Campo L, Fustinoni S, Consonni D, Pavanello S, Kapka L, Siwinska E, Mielzynska D, Bertazzi P. Urinary carcinogenic 4–6 ring polycyclic aromatic hydrocarbons in coke oven workers and in subjects belonging to the general population: Role of occupational and environmental exposure. Int J Hyg Environ Health. 2014;217:231–8.
73. Kuo CY, Chang SH, Chien YC, Chiang FY, Wei YC. Exposure to carcinogenic PAHs for the vendors of broiled food. J Exp Sci Environ Epidemiol. 2005;16:410–6.
74. Oh E, Lee E, Im H, Kang HS, Jung WW, Won NH, Kim EM, Sul D. Evaluation of immuno-and reproductive toxicities and association between immunotoxicological and genotoxicological parameters in waste incineration workers. Toxicoloxy. 2005;210:65–80.
75. Yang HH, Lai SO, Hsieh LT, Hsueh HJ, Chi TW. Profiles of PAH emission from steel and iron industries. Chemosphere. 2002;48:1061–74.
76. Unwin J, Cocker J, Scobbie E, Chambers H. An assessment of occupational exposure to polycyclic aromatic hydrocarbons in the UK. Ann Occup Hygiene. 2006;50:395–403.
77. Godschalk RW, Van Schooten FJ, Bartsch H. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J Biochem Mol Biol. 2003;36:1–11.
78. Breysse PN, Diette GB, Matsui EC, Butz AM, Hansel NN, McCormack MC. Indoor air pollution and asthma in children. Proc Am Thorac Soc. 2010;7:102–6.
79. Matsui EC, Hansel NN, McCormack MC, Rusher R, Breysse PN, Diette GB. Asthma in the inner city and the indoor environment. Immunol Allergy Clin North Am. 2008;28:665–86.
80. Klepeis NE, Nelson WC, Ott WR, Robinson JP, Tsang AM, Switzer P, Behar JV, Hern SC, Engelmann WH. The National Human Activity Pattern Survey (NHAPS): a resource for assessing exposure to environmental pollutants. J Expo Anal Environ Epidemiol. 2001;11:231–52.
81. Fiala Z, Vyskocil A, Krajak V, Viau C, Ettlerova E, Bukac J, Fialova D, Emminger S. Environmental exposure of small children to polycyclic aromatic hydrocarbons. Int Arch Occup Environ Health. 2001;74:411–20.
82. McCormack MC, Breysse PN, Matsui EC, Hansel NN, Williams D, Curtin-Brosnan J, Eggleston P, Dietter GB, Center for Childhood Asthma in Urban Envirnment. In-home particle concentrations and childhood asthma morbidity. Environ Health Perspect. 2009;117:294–98.
83. Diette GB, McCormack MC, Hansel NN, Breysse PN, Matsui EC. Environmental issues in managing asthma. Resp Care. 2008;53:602–17.
84. Murugesan A, Umarani C, Subramanian R, Nedunchezhian N. Biodiesel as an alternative fuel for diesel engines—a review. Renew Sust Energy Rev. 2009;13:653–62.
85. Karavalakis G, Boutsika V, Stournas S, Bakeas E. Biodiesel emissions profile in modern diesel vehicles. Part 2: Effect of biodiesel origin on carbonyl, PAH, nitro-PAH and oxy-PAH emissions. Sci Total Environ. 2011;409:738–47.
86. Wu S, Tao S, Liu W. Particle size distributions of polycyclic aromatic hydrocarbons in rural and urban atmosphere of Tianjin, China. Chemosphere. 2006;62:357–67.
87. Agency for Toxic Substances and Disease Registry. Toxicological profile for polycyclic aromatic hydrocarbons. Atlanta: Agency for Toxic Substances and Disease Registry; 1995.
88. Sinha R, Cross A, Curtin J, Zimmerman T, McNutt S, Risch A, Holden J. Development of a food frequency questionnaire module and databases for compounds in cooked and processed meats. Mol Nutr Food Res. 2005;49:648–55.
89. Keating GA, Bogen KT, Chan JM. Development of a meat frequency questionnaire for use in diet and cancer studies. J Am Diet Assoc. 2007;107:1356–62.
90. Deziel NC, Strickland PT, Platz EA, Abubaker S, Buckley TJ. Comparison of standard methods for assessing dietary intake of benzo [a] pyrene. Cancer Epidemiol Biomark Prev. 2011;20:962–70.
91. Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169:562–71.
92. Spiegelman D. Approaches to uncertainty in exposure assessment in environmental epidemiology. Ann Rev Public Health. 2010;31:149–63.
93. Strickland P, Kang D, Sithisarankul P. Polycyclic aromatic hydrocarbon metabolites in urine as biomarkers of exposure and effect. Environ Health Perspect. 1996;104:927.
94. Zhao ZH, Quan WY, Tian DH. Experiments on the effects of several factors on the 1-hydroxypyrene level in human urine as an indicator of exposure to polycyclic aromatic hydrocarbons. Sci Total Environ. 1992;113:197–207.
95. Kang D, Rothman N, Cho SH, Lim HS, Kwon HJ, Kim SM, Schwartz B, Strickland PT. Association of exposure to polycyclic aromatic hydrocarbons (estimated from job category) with concentration of 1-hydroxypyrene glucuronide in urine from workers at a steel plant. Occup Environ Med. 1995;52:593–9.
96. Sobus JR, Waidyanatha S, McClean MD, Herrick RF, Smith TJ, Garshick E, Ladan F, Hart JE, Zheng Y, Rappaport SM. Urinary naphthalene and phenanthrene as biomarkers of occupational exposure to polycyclic aromatic hydrocarbons. Occup Environ Med. 2009;66:99–104.
97. Krewski D, Jerrett M, Burnett RT, Ma R, Hughes E, Shi Y, Turner MC, Pope CA III, Thurston G, Calle EE, Thun MJ, Beckerman B, DeLUnca P, Finkelstein N, Ito K, Moore DK, Newbold KB, Ramsay T, Rozz Z, SHin H, Tempalski. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Res Rep Health Eff Inst. 2009;140:5–114.
98. Garza KM, Soto KF, Murr LE. Cytotoxicity and reactive oxygen species generation from aggregated carbon and carbonaceous nanoparticulate materials. Int J Nanomedicine. 2008;3:83–94.
99. Perera FP, Rauh V, Whyatt RM, Tsai WY, Tang D, Diaz D, Hoepner L, Barr D, Tu YH, Camann D, Kinney P. Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect. 2006;114:1287–92.
100. Perera FP, Li Z, Whyatt R, Hoepner L, Wang S, Camann D, Rauh V. Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years. Pediatrics. 2009;124:e195–202.
101. Jedrychowski W, Galas A, Pac A, Flak E, Camman D, Rauh V, Perera F. Prenatal ambient air exposure to polycyclic aromatic hydrocarbons and the occurrence of respiratory symptoms over the first year of life. Eur J Epidemiol. 2005;20:775–82.
102. Li Z, Sandau CD, Romanoff LC, Caudill SP, Sjodin A, Needham LL, Patterson DG Jr. Concentration and profile of 22 urinary polycyclic aromatic hydrocarbon metabolites in the US population. Environ Res. 2008;107:320–31.
103. Grainger J, Huang W, Patterson DG, Turner WE, Pirkle J, Caudill SP, Wang RY, Needham LL, Sampson EJ. Reference range levels of polycyclic aromatic hydrocarbons in the US population by measurement of urinary monohydroxy metabolites. Environ Res. 2006;100:394–423.
104. Al-Daghri NM, Alokail MS, Abd-Alrahman SH, Draz HM, Yakout SM, Clerici M. Polycyclic aromatic hydrocarbon exposure and pediatric asthma in children: a case-control study. Environ Health. 2013;12:1.
105. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev. 2014;23:700–13.
106. Karimi P, Shahrokni A, Ranjbar MR. Implementation of proteomics for cancer research: past, present, and future. Asian Pac J Cancer Prev. 2014;15:2433–8.
107. IARC. Polynuclear aromatic compounds. Part I: chemical, environmental and experimental data; 1983. Lyon: International Agency for Research on Cancer.
108. National Toxicology Program. Public Health Service, US Department of Health and Human Services, 12th report on carcinogens. Research Triangle Park, NC; 2011. p. 353–61.
109. NTP 12th report on carcinogens. Rep Carcinog. 2011;12(499):iii-499.
110. Jia Y, Stone D, Wang W, Schrlau J, Tao S, Simonich SL. Estimated reduction in cancer risk due to PAH exposures if source control measures during the 2008 Beijing Olympics were sustained. Environ Health Perspect. 2011;119:815–20.
111. Brauer M, Hoek G, Van Vliet P, Meliefste K, Fischer PH, Wijga A, Koopman LP, Gerritsen J, Kerkhof M, Heinrish J, Bellander T, Brunekreef B. Air pollution from traffic and the development of respiratory infections and asthmatic and allergic symptoms in children. Am J Respi Crit Care Med. 2002;166:1092–8.
112. Vork K, Broadwin R, Blaisdell R. Developing asthma in childhood from exposure to secondhand tobacco smoke: insights from a meta-regression. Cien Saude Colet. 2008;13:1313–25.
113. Strachan DP, Cook DG. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax. 1998;53:204–12.
114. Qian Z, Zhang J, Korn LR, Wei F, Chapman RS. Factor analysis of household factors: are they associated with respiratory conditions in Chinese children? Int J Epidemiol. 2004;33:582–8.
115. Burr M, Anderson H, Austin J, Harkins L, Kaur B, Strachan D, Warner JO. Respiratory symptoms and home environment in children: a national survey. Thorax. 1999;54:27–32.
116. Peabody JW, Riddell TJ, Smith KR, Liu Y, Zhao Y, Gong J, Milet M, Sinton JE. Indoor air pollution in rural China: cooking fuels, stoves, and health status. Arch Environ Occup Health. 2005;60:86–95.
117. Spira-Cohen A, Chen LC, Kendall M, Lall R, Thurston GD. Personal exposures to traffic-related air pollution and acute respiratory health among Bronx schoolchildren with asthma. Environ Health Perspect. 2011;119:559–65.
118. Patel MM, Miller RL. Air pollution and childhood asthma: recent advances and future directions. Curr Opin Pediatr. 2009;21:235–42.
119. Bell ML, Ebisu K, Peng RD, Dominici F. Adverse health effects of particulate air pollution: modification by air conditioning. Epidemiology. 2009;20:682–6.
120. Miller RL, Garfinkel R, Horton M, Camann D, Perera FP, Whyatt RM, Kinney PL. Polycyclic aromatic hydrocarbons, environmental tobacco smoke, and respiratory symptoms in an inner-city birth cohort. Chest. 2004;126:1071–8.
121. Rosa MJ, Jung KH, Perzanowski MS, Kelvin EA, Darling KW, Camann DE, Chillrud SN, Whyatt RM, Kinney PL, Perera FP, Miller RL. Prenatal exposure to polycyclic aromatic hydrocarbons, environmental tobacco smoke and asthma. Respir Med. 2011;105:869–76.
122. Nadeau K, McDonald-Hyman C, Noth EM, Pratt B, Hammond SK, Balmes J, Tager I. Ambient air pollution impairs regulatory T-cell function in asthma. J. Allergy Clin Immunol. 2010;126:845–52.
123. Miller RL, Garfinkel R, Lendor C, Hoepner L, Li Z, Romanoff L, Sjodin A, Needham L, Perera FP, Whayatt RM. Polycyclic aromatic hydrocarbon metabolite levels and pediatric allergy and asthma in an inner-city cohort. Pediatr Allergy Immunol. 2010;21:260–7.
124. Karimi P, Modarresi SZ, Sahraian MA, Shoormasti RS, Mahlooji M, Kazemnejad A, Pourpak Z. The relation of multiple sclerosis with allergy and atopy: a case control study. Iran J Allergy Asthma Immunol. 2013;12:182–9.
125. Perzanowski MS, Chew GL, Divjan A, Jung KH, Ridder R, Tang D, Diaz D, Goldstein IF, Kinney PL, Rundle AG, Camann DE, Perera FP, Miller RL. Early-life cockroach allergen and polycyclic aromatic hydrocarbon exposures predict cockroach sensitization among inner-city children. J Allergy Clin Immunol. 2013;131:886–93.
126. Tsien A, Diaz-Sanchez D, Ma J, Saxon A. The organic component of diesel exhaust particles and phenanthrene, a major polyaromatic hydrocarbon constituent, enhances IgE production by IgE-secreting EBV-transformed human B cells in vitro. Toxicol Appl Pharmacol. 1997;142:256–63.
127. Nel AE, Diaz-Sanchez D, Ng D, Hiura T, Saxon A. Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. J Allergy Clin Immunol. 1998;102:539–54.
128. Lubitz S, Schober W, Pusch G, Effner R, Klopp N, Behrendt H, Buters JT. Polycyclic aromatic hydrocarbons from diesel emissions exert proallergic effects in birch pollen allergic individuals through enhanced mediator release from basophils. Environ Toxicol. 2010;25:188–97.
129. Xiao GG, Nel AE, Loo JA. Nitrotyrosine-modified proteins and oxidative stress induced by diesel exhaust particles. Electrophoresis. 2005;26:280–92.
130. Kanoh T, Suzuki T, Ishimori M, Ikeda S, Ohasawa M, Ohkuni H, Tunetoshi Y. Adjuvant activities of pyrene, anthracene, fluoranthene and benzo(a)pyrene in production of anti-IgE antibody to Japanese cedar pollen allergen in mice. J Clin Lab Immunol. 1996;48:133–47.
131. Bommel H, Li-Weber M, Serfling E, Duschl A. The environmental pollutant pyrene induces the production of IL-4. J Allergy Clin Immunol. 2000;105:796–802.
132. Cao Y, DePinho RA, Ernst M, Vousden K. Cancer research: past, present and future. Nat Rev Cancer. 2011;11:749–54.
133. Diaz-Sanchez D, Dotson AR, Takenaka H, Saxon A. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest. 1994;94:1417–25.
134. Riedl MA, Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol. 2008;8:49–56.
135. van Voorhis M, Knopp S, Julliard W, Fechner JH, Zhang X, Schauer JJ, Mezrich JD. Exposure to atmospheric particulate matter enhances Th17 polarization through the aryl hydrocarbon receptor. PLoS ONE. 2013;8:e82545.
136. Brandt EB, Kovacic MB, Lee GB, Gibson AM, Acciani TH, Le Cras TD, Ryan PH, Budelsky AL, Khurana Hershey GK. Diesel exhaust particle induction of IL-17A contributes to severe asthma. J Allergy Clin Immunol. 2013;132:1194–204.
137. Li N, Wang M, Bramble LA, Schmitz DA, Schauer JJ, Sioutas C, Harkema JR, Nel AE. The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential. Environ Health Perspect. 2009;117:1116–23.
138. Mastrangelo G, Clonfero E, Pavanello S, Fedeli U, Fadda E, Turato A, Piccinni S, Montagnani R, Marcer G. Exposure to diesel exhaust enhances total IgE in non-atopic dockers. Int Arch Occup Environ Health. 2003;76:63–8.
139. Pandya RJ, Solomon G, Kinner A, Balmes JR. Diesel exhaust and asthma: Hypotheses and molecular mechanisms of action. Environ Health Perspect. 2002;110:103–12.
140. Cho YS, Moon HB. The role of oxidative stress in the pathogenesis of asthma. Allergy Asthma Immunol Res. 2010;2(3):183–7.
141. Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, Wang M, Oberley T, Froines J, Nel A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect. 2003;111:455–60.
142. Nel AE, Diaz-Sanchez D, Li N. The role of particulate pollutants in pulmonary inflammation and asthma: evidence for the involvement of organic chemicals and oxidative stress. Curr Opin Pulm Med. 2001;7:20–6.
143. Ghabaee M, Bayati A. Saroukolaei SA, Sahraian MA, Sanaati MH, Karimi P, Houshmand M, Sadeghian H, Hashemi Chelavi L. Analysis of HLA DR2&DQ6 (DRB1* 1501, DQA1* 0102, DQB1* 0602) haplotypes in Iranian patients with multiple sclerosis. Cell Mol Neurobiol. 2009;29:109–14.
144. Rezaee AR, Azadi A, Houshmand M, Mahmoodi F, Purpak Z, Safaei S, Karimi P, Ghabaee M, Sahraian MA. Mitochondrial and nuclear genes as the cause of complex I deficiency. Genet Mol Res. 2012;12:3551–4.
145. Vattanasit U, Navasumrit P, Khadka MB, Kanitwithayanun J, Promvijit J, Autrup H, Ruchirawat M. Oxidative DNA damage and inflammatory responses in cultured human cells and in humans exposed to traffic-related particles. Int J Hyg Environ Health. 2014;217:23–33.
146. Chu S, Zhang H, Maher C, McDonald JD, Zhang X, Ho SM, Yan B, Chillrud S, Perera F, Factor P, Miller RL. Prenatal and postnatal polycyclic aromatic hydrocarbon exposure, airway hyperreactivity, and Beta-2 adrenergic receptor function in sensitized mouse offspring. J Toxicol. 2013. doi:10.1155/2013/603581.
147. Jedrychowski WA, Perera FP, Maugeri U, Majewska R, Mroz E, Flak E, Camann D, Sowa A, Jacek R. Long term effects of prenatal and postnatal airborne PAH exposures on ventilatory lung function of non-asthmatic preadolescent children. Prospective birth cohort study in Krakow. Sci Total Environ. 2015;502:502–9.
148. Sram RJ, Binkova B, Dostal M, Merkerova-Dostalova M, Libalova H, Milcova A, Rossner P Jr, Rossnerova A, Schmuczerova J, Svecova V, Topinka J, Votavova H. Health impact of air pollution to children. Int J Hyg Environ Health. 2013;216:533–40.
149. Perera F, Herbstman J. Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol. 2011;31:363–73.
150. Brown LNA, Khousbouei H, Goodwin JS, Irvin-Wilson CV, Ramesh A, Sheng L, McCallister MM, Jiang GC, Aschner M, Hood DB. Down-regulation of early ionotrophic glutamate receptor subunit developmental expression as a mechanism for observed plasticity deficits following gestational exposure to benzo pyrene. Neurotoxicology. 2007;28:965–78.
151. Rusling JF, Kumar CV, Gutkind JS, Patel V. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst. 2010;135:2496–511.